Zhao et al. [22] showed that compared with TACE therapy alone, TACE combined with Fufang Banmao capsule could increase human CD3+ and CD4+ cells, and Fufang Banmao capsules could inhibit the proliferation of liver cancer cells by inhibiting the expression of the c-Myc gene and promoting the expression of the p53 gene. The gene discussed is TP53; the disease is liver cancer.